Wikidata entity: Q422273
C₁₈H₃₃ClN₂O₅S (P274)
Quantities
| P4250 | defined daily dose | 0.1 |
| P2067 | mass | 424.179871 |
| P3780 | active ingredient in | ... | Q47521363 (Cleocin) | Cleocin |
| P3780 | active ingredient in | ... | Q47521367 (Clindacin) | Clindacin |
| P3780 | active ingredient in | ... | Q47521368 (Clindagel) | Clindagel |
| P3780 | active ingredient in | ... | Q47521369 (Clindamax) | Clindamax |
| P3780 | active ingredient in | ... | Q47521582 (Evoclin) | Evoclin |
| P3780 | active ingredient in | ... | Q48826141 (Clindets) | Clindets |
| P3780 | active ingredient in | ... | Q48826299 (Cleocin-T) | Cleocin-T |
| P3780 | active ingredient in | ... | Q48828179 (Clindesse) | Clindesse |
| P3780 | active ingredient in | ... | Q48828827 (ANTIROBE) | ANTIROBE |
| P233 | canonical SMILES | String | CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl | ??? |
| P373 | Commons category | String | Clindamycin | ??? |
| P1552 | has characteristic | ... | Q1517187 (bitterness) | bitterness |
| P527 | has part(s) | ... | Q627 (nitrogen) | nitrogen |
| P527 | has part(s) | ... | Q623 (carbon) | carbon |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q59199015 (group of stereoisomers) | group of stereoisomers |
| P2017 | isomeric SMILES | String | CCC[C@@H]1C[C@H](N(C1)C)C(=O)NC([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)C(C)Cl | ??? |
| P3493 | legal status (medicine) | ... | Q879952 (boxed warning) | boxed warning |
| P8026 | LiverTox likelihood score | ... | Q83284157 (LiverTox toxicity likelihood category B) | LiverTox toxicity likelihood category B |
| P2175 | medical condition treated | ... | Q79928 (acne) | acne |
| P2175 | medical condition treated | ... | Q34879 (staphylococcal infection) | staphylococcal infection |
| P2175 | medical condition treated | ... | Q154865 (botulism) | botulism |
| P2175 | medical condition treated | ... | Q154878 (toxoplasmosis) | toxoplasmosis |
| P2175 | medical condition treated | ... | Q183344 (sinusitis) | sinusitis |
| P2175 | medical condition treated | ... | Q186470 (tonsillitis) | tonsillitis |
| P2175 | medical condition treated | ... | Q804521 (bacterial vaginosis) | bacterial vaginosis |
| P2175 | medical condition treated | ... | Q876887 (cellulitis) | cellulitis |
| P2175 | medical condition treated | ... | Q2458539 (skin infection) | skin infection |
| P2175 | medical condition treated | ... | Q2710164 (dental abscess) | dental abscess |
| P2175 | medical condition treated | ... | Q7205993 (pneumocystosis) | pneumocystosis |
| P2175 | medical condition treated | ... | Q18975970 (bacteroides infectious disease) | bacteroides infectious disease |
| P3489 | pregnancy category | ... | Q3679189 (Australian pregnancy category A) | Australian pregnancy category A |
| P3489 | pregnancy category | ... | Q28123616 (US pregnancy category B) | US pregnancy category B |
| P636 | route of administration | ... | Q285166 (oral administration) | oral administration |
| P636 | route of administration | ... | Q6058566 (intravaginal administration) | intravaginal administration |
| P636 | route of administration | ... | Q29954029 (parenteral route of administration) | parenteral route of administration |
| P279 | subclass of | ... | Q193430 (heterocyclic compound) | heterocyclic compound |
| P279 | subclass of | ... | Q422235 (lincosamides) | lincosamides |
| P2868 | subject has role | ... | Q12187 (antibiotic) | antibiotic |
| P2868 | subject has role | ... | Q35456 (essential medicine) | essential medicine |
| P2868 | subject has role | ... | Q7251505 (protein synthesis inhibitor) | protein synthesis inhibitor |
| P12081 | WHO Aware Classification | ... | Q122924881 (access) | access |
Why not click here or view trends?
log id: 3861620